Bioidentical hormone therapy works well and secure for menopausal women Life Expansion.

Bioidentical hormone therapy works well and secure for menopausal women Life Expansion, the business that way back when sounded the alarm on the risks of synthetic hormone substitute therapy for menopausal ladies, has published even now more evidence that bioidentical hormones provide a much safer treatment choice. A white paper entitled Bioidentical Hormones: HOW COME There Still a Controversy, in the October edition of Life Expansion Magazine published, provides compelling scientific proof on the protection and efficiency of bioidentical hormone therapy tadalafil czech .

.. Bio-Route initiates enrollment in 4th cohort of Liposomal Grb-2 Phase We trial for blood cancers Bio-Route Holdings, Inc., , a biotechnology company creating a liposomal delivery technology for nucleic acid cancer drugs, announced that it has started enrolling sufferers into today the 4th dosage cohort in its Stage I scientific trial of its lead product candidate, BP-100.1.01 , which has been evaluated mainly because a systemic treatment for bloodstream cancers including acute myeloid leukemia , chronic myelogenous leukemia , severe lymphoblastic leukemia and myelodysplastic syndrome . The Phase I trial includes five cohorts altogether.